1-3 of 3
Miranda Fernández-Serrano
Close
Sort by
Journal Articles

Multiomic Characterization of Myelodysplastic Neoplasms (MDS) with Micromegakaryocytes Highlights the Role of EZH2-RUNX1 deregulation in Disease Physiopathology and Response to Targeted Therapies

Miranda Fernandez-Serrano, Alba Mesa, Ignacio Campillo-Marcos, Marta Casado-Pelaez, Shubhra Bhattacharya, Laura Palomo, Wencke Walter, Pau Marin-Escudero, Mar Mallo, Julia Montoro, Francesc Sole, Elisabetta Mereu, Caterina Mata, David Corujo, Torsten Haferlach, Marcus Buschbeck, Manel Esteller, David Valcarcel, Silvia Saumell, Gael Roue
Journal: Blood
Blood (2023) 142 (Supplement 1): 4116.
https://doi.org/10.1182/blood-2023-188848
Published: 2023
Journal Articles

Narazaciclib, a Differentiated CDK4/6 Antagonist, Prolongs Cell Cycle Arrest and Metabolomic Reprogramming, Enabling Restoration of Ibrutinib Sensitivity in Btki-Resistant Mantle Cell Lymphoma

Nuria Profitos-Peleja, Marcelo Lima Ribeiro, Jeronimo Parra, Miranda Fernandez-Serrano, Pau Marin-Escudero, Joan Josep Bech, Carolina De La Torre, Adar Makovski Silverstein, Steve Cosenza, Steven M. Fruchtman, Manel Esteller, Gael Roue
Journal: Blood
Blood (2023) 142 (Supplement 1): 4181.
https://doi.org/10.1182/blood-2023-189838
Published: 2023
Journal Articles

The Ublituximab-Umbralisib (U2) Drug Regimen Potentiates the Activity of the Novel CD47-CD19 Bispecific Antibody, TG-1801, through the Activation of the G Protein-Coupled Receptor EBI2/GPR183

Emmanuel Normant, Marcelo Lima Ribeiro, Nuria Profitos-Peleja, Pedro Blecua, Diana Reyes-Garau, Juliana Carvalho Santos, Marc Armengol, Miranda Fernández-Serrano, Hari P. Miskin, Gael Roue
Journal: Blood
Blood (2021) 138 (Supplement 1): 1196.
https://doi.org/10.1182/blood-2021-150570
Published: 2021